3rd Oral Drug Formulation Innovations (ccr) AS

Event Information

Share this event

Date and Time

Location

Location

Philadelphia

Philadelphia, PA 0000

View Map

Event description

Description

3rd Oral Drug Formulation Innovations

June 26-27, 2019 | Philadelphia, PA


Uncovering the Future of Formulation Development, Oral Drug Delivery and Innovative Strategies to Accelerate Drug Product Time-To-Market

In today’s high-risk, overcrowded and highly regulated drug development marketplace, we understand the drug development industry is in critical need of innovative formulation approaches and methodologies in order to get new approved oral drug products to market in a timely fashion.

The 3rd Annual Oral Drug Formulation Innovations Summit will showcase the industry’s latest formulation and delivery technologies for enhancing solubility and maximizing bioavailability. Learn directly from leading global formulation experts in both industry and academia on how to effectively develop poorly soluble drugs into scientifically unique, compliant, patient-centric formulations. Additionally, learn innovative strategies to significantly reduce product development timelines, brush up on the latest regulatory requirements and learn multiple innovative strategies to optimize and enhance your product portfolio.

Breakthrough innovations in the next generation of drug products: A new thinking for formulation design
Creating next generation products: Evaluating innovations in oral drug formulation and delivery technologies
Beyond the pill: Addressing future patient needs through the importance of pharmaceutical profiling
Understanding and establishing the right conditions for IVIVC correlation
Utilizing nanoparticles for the development of the next generation of drug products
Effective formulation development strategies for improving oral bioavailability of poorly water-soluble drugs
Characterization of amorphous materials to advance product development
Spray-dried dispersion formulations in suspensions and solid dosage forms
Combining In-Vivo animal models with physiologically-based PBPK modeling
Novel Life Cycle management strategies for poorly soluble drugs


Leading session topics and takeaways include:

  • Breakthrough innovations in the next generation of drug products: A new thinking for formulation design

  • Creating next generation products: Evaluating innovations in oral drug formulation and delivery technologies

  • Beyond the pill: Addressing future patient needs through the importance of pharmaceutical profiling

  • Effective formulation development strategies for improving oral bioavailability of poorly water-soluble drugs

  • Characterization of amorphous materials to advance product development

  • Spray-dried dispersion formulations in suspensions and solid dosage forms

  • Combining In-Vivo animal models with physiologically-based PBPK modeling


Why Attend?

  • 20+ industry-led speaker faculty over 2 full days sharing innovative take-home strategies

  • 100+ senior participants spanning pharma, biotech, regulatory and specialty delivery and formulation providers

  • 5+ hours of networking and breakout sessions, including pre-conference meet up & evening cocktail reception

  • Exhibit hall with leading formulation experts



Speakers

Esmaiel Jabbri, PhD.

Esmaiel Jabbri, PhD.

Professor of Chemical Engineering, University of South Carolina

Abla Creasey, PhD.

Abla Creasey, PhD.

Associate Director- Therapeutics at California Institute for Regenerative Medicine

Robert Prud'Homme, PhD.

Robert Prud'Homme, PhD.

Professor and Director Program in Engr. Biology, Princeton University


Ilgaz Akseli, PhD., MBA

Ilgaz Akseli, PhD., MBA

Head of Formulation Profiling and Process Modeling, Boehringer Ingelheim

Sudhakar Garad, PhD.

Sudhakar Garad, PhD.

Global Head of Chemical and Pharmaceutical Profiling, Novartis



Varsha Biyyala, PhD.

Varsha Biyyala, PhD.

Senior Formulation Scientist, Oral Dosage Forms, Merck & Co.



Dhaval Patel, PhD.

Dhaval Patel, PhD.

Senior Research Investigator, Bristol Myers Squibb

Faraj Atassi, PhD.

Faraj Atassi, PhD.

Principal Scientist, Chemical and Pharmaceutical Profiling, Novartis

Wei Zhu, PhD.

Wei Zhu, PhD.

Associate Principal Scientist, Biopharmaceutics Pharmaceutical Sciences and Clinical Supply, Merck & Co.

John Morrison, PhD.

John Morrison, PhD.

Senior Research Investigator, Bristol Myers Squibb

David Cipolla, PhD.

David Cipolla, PhD.

Senior Director of Pharmaceutical Science, Aradigm

Boris Shekunov, PhD.

Boris Shekunov, PhD.

Senior Principal Scientist, Director, Analytical Technology, Global Pharmaceutical Technology, Shire Pharmaceuticals

René Holm, PhD.

René Holm, PhD.

Head and Scientific Director, Liquids & Parenterals, The Janssen Pharmaceutical Companies of Johnson & Johnson

Marian Gindy, PhD.

Marian Gindy, PhD.

Director, Parenteral Products Development, Merck & Co.

David Schoneker, PhD.

David Schoneker, PhD.

Director, Global Regulatory Affairs, Colorcon

Niya Bowers, PhD.

Niya Bowers, PhD.

Senior Program Officer at Bill & Melinda Gates Foundation

Sudhakar Garad, PhD.

Sudhakar Garad, PhD.

Global Head of Chemical and Pharmaceutical Profiling, Novartis



Please contact the event manager Marilyn (marilyn.b.turner@nyeventslist.com ) below for:
- Multiple participant discounts
- Price quotations or visa invitation letters
- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
- Event sponsorships

NO REFUNDS ALLOWED ON REGISTRATIONS
Service fees included in this listing.
-----------------------------------------------------------------
Curtis & Coulter LLC. - New York Events List
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com
-----------------------------------------------------------------

MYL190115CEV

Share with friends

Date and Time

Location

Philadelphia

Philadelphia, PA 0000

View Map

Save This Event

Event Saved